@article{discovery1536724,
           pages = {278--287},
            note = {{\copyright} 2017. This manuscript version is published under a Creative Commons Attribution Non-commercial Non-derivative 4.0 International licence (CC BY-NC-ND 4.0). This licence allows you to share, copy, distribute and transmit the work for personal and non-commercial use providing author and publisher attribution is clearly stated. Further details about CC BY licences are available at http://creativecommons.org/licenses/by/4.0. Access may be initially restricted by the publisher.},
          volume = {120},
         journal = {Mol Genet Metab},
            year = {2017},
           title = {Consensus clinical management guideline for pantothenate kinase-associated neurodegeneration (PKAN).},
          number = {3},
           month = {March},
             url = {http://dx.doi.org/10.1016/j.ymgme.2016.11.004},
        abstract = {- Clinical experts have developed consensus opinions about the management of PKAN that can serve as a guideline for care.

- Guidance is provided for diagnosis and management, treatment and surveillance, including for status dystonicus and other emergency care, and education and psychosocial support.

- This guideline is a living document that will require ongoing review and revision.},
            issn = {1096-7206},
          author = {Hogarth, P and Kurian, MA and Gregory, A and Cs{\'a}nyi, B and Zagustin, T and Kmiec, T and Wood, P and Klucken, A and Scalise, N and Sofia, F and Klopstock, T and Zorzi, G and Nardocci, N and Hayflick, SJ}
}